OA
Insider buying
Orbimed Advisors LLC bought $34.9M of BRVE stock
Orbimed Advisors LLC, Dir, 10% of Braveheart Bio, Inc. (BRVE), bought 1,940,000 shares of BRVE stock worth $34.9M, per an SEC Form 4 filed Aug 11, 2026.
The shares came through a private deal, not the open market.
The trade happened on Aug 7, 2026, 4 days before it was made public.
BRVE has moved -29.9% since the trade date, from $30.00 to $21.04 (Oct 21, 2026 close).
- Traded
- Aug 7, 2026
- Disclosed
- Aug 11, 2026
- Filing delay
- 4 days
- Price since
- -29.9%
- Role
- Dir, 10%
- Source
- SEC Form 4
More BRVE insider and Congress trades
- BuyBRVE · Erez Chimovits$34.9MAug 11, 2026
- BuyBRVE · AH Bio Fund IV, L.P.$19.8MAug 11, 2026
- BuyBRVE · Forbion Growth Opportunities Fund III Cooperatief U.A.$64.8MAug 7, 2026
- BuyBRVE · Travis Murdoch$1.5MAug 7, 2026
- BuyBRVE · David Charles Lubner$1000KAug 7, 2026
- BuyBRVE · James Paul Rickey$500KAug 7, 2026
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.